CCTV News: The National Health Insurance Administration of China announced the 2024 statistical report on the development of medical insurance in 2024, including insurance participation, medical treatment in other places, drug consumption procurement, maternity insurance and other contents. In 2024, the basic medical insurance participation rate will be stable at 95%, and the medical insurance fund will achieve a surplus of more than 510 billion yuan this year, and the revenue and expenditure situation will be stable.

According to the express report, 1326.3783 million people participated in the basic medical insurance in 2024, the quality of insurance participation continued to improve, the insurance structure was further optimized, and the insurance rate was consolidated at 95%. The insurance coverage rate of low-income and people who have been lifted out of poverty is stable at more than 99%. 25 provinces that undertake the original poverty alleviation task have funded 86.23 million insured people.

In 2024, employees and residents will achieve "double surplus" this year

The total revenue of the medical insurance fund in 2024 will be 3.48 trillion yuan, total expenditure will be 2.97 trillion yuan, and the surplus will be more than 510 billion yuan this year. The revenue and expenditure situation will be stable. Both the employee medical insurance and the resident medical insurance coordinated funds have achieved balances within the year. In 2024, the demand for outpatient medical treatment continued to be released rapidly and significantly increased, and the number of employees and residents who enjoyed treatment in outpatient clinics exceeded 3 billion.

Deputy Director of the Department of Regulation, Finance and Regulations of the State Medical Insurance Administration Zhang Chenguang: my country's nearly 3 trillion yuan of medical insurance fund expenditures have been heavily woven and tightened by a proportion of only 2.2% of GDP. The cumulative balance of the 3.8 trillion yuan unified fund is a solid support for everyone to seek medical treatment with confidence.

91 new drug catalog adjustment in 2024

According to the express report, 91 new drug catalog adjustments in 2024, reaching 3159; the number of people directly settled for hospitalizations across provinces and outpatients increased by 27.37%, the number of people directly settled for outpatients in outpatients increased by 90.18%, and the number of people directly settled for outpatients across provinces and outpatients increased from 5 to 10. In the seven years since the establishment of the National Health Insurance Administration, the cumulative expenditure of medical insurance funds has exceeded 16.5 trillion yuan, with an average annual growth rate of 11%.

The centralized volume procurement of drugs and consumables continues to expand

In 2024, the centralized volume procurement of drugs and consumables continues to expand, from Western medicine and chemical medicine to Chinese patent medicine and Chinese herbal medicines; the centralized procurement of consumables has added two types of cochlear implants and peripheral vascular stents.

The time from the launch of innovative drugs to the inclusion of medical insurance has been greatly shortened. During the period of the new drug agreement for medical insurance negotiations from 2018 to 2024, sales revenue exceeded 540 billion yuan, of which the medical insurance fund expenditure exceeded 370 billion yuan.